LifeStance Health Group, Inc.·4

Mar 11, 7:00 PM ET

Varanakis Ann 4

Research Summary

AI-generated summary

Updated

LifeStance (LFST) CPO Ann Varanakis Receives Award; Shares Withheld

What Happened
Ann Varanakis, Chief People Officer of LifeStance Health Group (LFST), received equity awards that vested on March 9, 2026: 86,625 shares were reported as acquired (award/vesting). To satisfy tax withholding on the net settlement, 44,963 shares were withheld at $6.91/share (total value withheld ≈ $310,694). These withholdings are reductions of the shares issued upon vesting and are not open-market sales. Net shares issued to Varanakis after withholding: 41,662.

Key Details

  • Transaction date: March 9, 2026; Form 4 filed March 11, 2026 (appears timely within the two-business-day window).
  • Awarded (A): 26,836 and 59,789 shares (total 86,625) — vested RSUs/PSUs from prior grants (see footnotes).
  • Withheld for taxes (F): 8,707; 11,232; 25,024 shares (total 44,963) at $6.91/share, totaling ≈ $310,694.
  • Net newly issued to insider after withholding: 41,662 shares (86,625 − 44,963).
  • Shares owned after the transaction: not specified in the provided filing details.
  • Footnotes: awards include performance-based RSUs/PSUs granted March 6, 2025 and February 27, 2025; F codes denote tax withholding via net settlement (not open-market sales).

Context
These entries reflect vested equity awards and routine corporate tax withholding (net settlement). This is not a purchase or an open-market sale by the insider. For retail investors, vested awards and tax-withholding actions are common compensation events and generally do not, by themselves, indicate the insider’s view on the company’s stock.